These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
239 related items for PubMed ID: 9563903
1. Infrequent mutation of the p16/MTS1 gene and overexpression of cyclin-dependent kinase 4 in human primary soft-tissue sarcoma. Yao J, Pollock RE, Lang A, Tan M, Pisters PW, Goodrich D, El-Naggar A, Yu D. Clin Cancer Res; 1998 Apr; 4(4):1065-70. PubMed ID: 9563903 [Abstract] [Full Text] [Related]
2. No p16INK4A/CDKN2/MTS1 mutations independent of p53 status in soft tissue sarcomas. Meye A, Würl P, Hinze R, Berger D, Bache M, Schmidt H, Rath FW, Taubert H. J Pathol; 1998 Jan; 184(1):14-7. PubMed ID: 9582521 [Abstract] [Full Text] [Related]
3. Aberrant expression of cell-cycle regulatory proteins in human mesenchymal neoplasia. Creager AJ, Cohen JA, Geradts J. Cancer Detect Prev; 2001 Jan; 25(2):123-31. PubMed ID: 11341347 [Abstract] [Full Text] [Related]
4. Among genes involved in the RB dependent cell cycle regulatory cascade, the p16 tumor suppressor gene is frequently lost in the Ewing family of tumors. Kovar H, Jug G, Aryee DN, Zoubek A, Ambros P, Gruber B, Windhager R, Gadner H. Oncogene; 1997 Oct; 15(18):2225-32. PubMed ID: 9393981 [Abstract] [Full Text] [Related]
5. Altered mRNA expression of the Rb and p16 tumor suppressor genes and of CDK4 in transitional cell carcinomas of the urinary bladder associated with tumor progression. Quentin T, Henke C, Korabiowska M, Schlott T, Zimmerman B, Kunze E. Anticancer Res; 2004 Oct; 24(2B):1011-23. PubMed ID: 15161057 [Abstract] [Full Text] [Related]
7. Role of p16/MTS1, cyclin D1 and RB in primary oral cancer and oral cancer cell lines. Sartor M, Steingrimsdottir H, Elamin F, Gäken J, Warnakulasuriya S, Partridge M, Thakker N, Johnson NW, Tavassoli M. Br J Cancer; 1999 Apr; 80(1-2):79-86. PubMed ID: 10389982 [Abstract] [Full Text] [Related]
8. Immunohistochemical detection of the cyclin-dependent kinase inhibitor 2/multiple tumor suppressor gene 1 (CDKN2/MTS1) product p16INK4A in archival human solid tumors: correlation with retinoblastoma protein expression. Geradts J, Kratzke RA, Niehans GA, Lincoln CE. Cancer Res; 1995 Dec 15; 55(24):6006-11. PubMed ID: 8521382 [Abstract] [Full Text] [Related]
9. Homozygous deletion of the MTS1/p16 and MTS2/p15 genes and amplification of the CDK4 gene in glioma. Sonoda Y, Yoshimoto T, Sekiya T. Oncogene; 1995 Nov 16; 11(10):2145-9. PubMed ID: 7478535 [Abstract] [Full Text] [Related]
10. The p16-cyclin D/Cdk4-pRb pathway as a functional unit frequently altered in melanoma pathogenesis. Bartkova J, Lukas J, Guldberg P, Alsner J, Kirkin AF, Zeuthen J, Bartek J. Cancer Res; 1996 Dec 01; 56(23):5475-83. PubMed ID: 8968104 [Abstract] [Full Text] [Related]
11. Disruption of the cyclin D/cyclin-dependent kinase/INK4/retinoblastoma protein regulatory pathway in human neuroblastoma. Easton J, Wei T, Lahti JM, Kidd VJ. Cancer Res; 1998 Jun 15; 58(12):2624-32. PubMed ID: 9635589 [Abstract] [Full Text] [Related]
12. Interaction of retinoblastoma protein and D cyclins during cell-growth inhibition by hexamethylenebisacetamide in TM2H mouse epithelial cells. Said TK, Medina D. Mol Carcinog; 1998 Jun 15; 22(2):128-43. PubMed ID: 9655257 [Abstract] [Full Text] [Related]
13. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16. Lukas J, Parry D, Aagaard L, Mann DJ, Bartkova J, Strauss M, Peters G, Bartek J. Nature; 1995 Jun 08; 375(6531):503-6. PubMed ID: 7777060 [Abstract] [Full Text] [Related]
14. Multiple mechanisms of p16INK4A inactivation in non-small cell lung cancer cell lines. Shapiro GI, Park JE, Edwards CD, Mao L, Merlo A, Sidransky D, Ewen ME, Rollins BJ. Cancer Res; 1995 Dec 15; 55(24):6200-9. PubMed ID: 8521414 [Abstract] [Full Text] [Related]
15. Amplification of the CDK4 gene in sarcomas: tumor specificity and relationship with the RB gene mutation. Kanoe H, Nakayama T, Murakami H, Hosaka T, Yamamoto H, Nakashima Y, Tsuboyama T, Nakamura T, Sasaki MS, Toguchida J. Anticancer Res; 1998 Dec 15; 18(4A):2317-21. PubMed ID: 9703873 [Abstract] [Full Text] [Related]
16. Alterations in the regulatory pathway involving p16, pRb and cdk4 in human chondrosarcoma. Asp J, Inerot S, Block JA, Lindahl A. J Orthop Res; 2001 Jan 15; 19(1):149-54. PubMed ID: 11332612 [Abstract] [Full Text] [Related]
17. Expression of the cell-cycle regulatory proteins (pRb, cyclin D1, p16INK4A and cdk4) in human endometrial cancer: correlation with clinicopathological features. Semczuk A, Miturski R, Skomra D, Jakowicki JA. Arch Gynecol Obstet; 2004 Jan 15; 269(2):104-10. PubMed ID: 14648178 [Abstract] [Full Text] [Related]
18. Role of cdk4, p16INK4, and Rb expression in the prognosis of bronchioloalveolar carcinomas. Ghazizadeh M, Jin E, Shimizu H, Fujiwara M, Arai S, Ohaki Y, Takemura T, Kawanami O. Respiration; 2005 Jan 15; 72(1):68-73. PubMed ID: 15753637 [Abstract] [Full Text] [Related]
19. Growth inhibitory effect on glioma cells of adenovirus-mediated p16/INK4a gene transfer in vitro and in vivo. Lee SH, Kim MS, Kwon HC, Park IC, Park MJ, Lee CT, Kim YW, Kim CM, Hong SI. Int J Mol Med; 2000 Nov 15; 6(5):559-63. PubMed ID: 11029524 [Abstract] [Full Text] [Related]
20. Regulation of androgen-dependent prostatic cancer cell growth: androgen regulation of CDK2, CDK4, and CKI p16 genes. Lu S, Tsai SY, Tsai MJ. Cancer Res; 1997 Oct 15; 57(20):4511-6. PubMed ID: 9377562 [Abstract] [Full Text] [Related] Page: [Next] [New Search]